FINWIRES · TerminalLIVE
FINWIRES

Lupin Teams Up with Laboratorios ERN for Asthma, COPD Drug Launch in Spain

By

Lupin (NSE:LUPIN, BOM:500257) has partnered with Spain-based Laboratorios ERN for the launch of the Luforbec inhaler in the Spanish market, according to a Monday filing on Indian bourses.

The product is a fixed-dose combination of beclometasone and formoterol for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD), the filing said.

The partnership will support the commercialization of the product in Spain.

Shares of Lupin fell nearly 1% in recent trade.

Related Articles